Advances in Endometrial Cancer Therapy: Exploring the Role of Immunotherapy

Bolster your practice with evidence-based guidance from an international panel of experts on endometrial cancer in this interactive expert-authored activity and audio podcasts. Download the slides for use in your own presentations.

This educational program is intended for clinicians practicing medicine outside of the United States.

Share

Program Content

Activities

EC Classification
Molecular Classification of Endometrial Carcinoma in the Clinic Today
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: November 11, 2020

Expires: November 10, 2021

EC Immunotherapy
Advances in Immunotherapy for Endometrial Cancer
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: November 11, 2020

Expires: November 10, 2021

Activities

EC Classification
Molecular Classification of Endometrial Carcinoma in the Clinic Today
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 12, 2020

Expires: November 11, 2021

EC Immunotherapy
Advances in Immunotherapy for Endometrial Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: November 12, 2020

Expires: November 11, 2021

Activities

IO in Endometrial Cancer
Advances in Endometrial Cancer Therapy: Exploring the Role of Immunotherapy
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: December 22, 2020

Expires: December 21, 2021

Activities

Endometrial Cancer IO Therapy
Advances in Endometrial Cancer Therapy: Exploring the Role of Immunotherapy
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: December 22, 2020

Expires: December 21, 2021

Faculty

cover img faculity

Ana Oaknin, MD, PhD

Head of Gynaecologic Cancer Programme
Department of Medical Oncology
Vall d’ Hebron University Hospital
Vall d’Hebron Institute of Oncology (VHIO)
Barcelona, Spain

Supporters

Supported by an educational grant from

GlaxoSmithKline